301 related articles for article (PubMed ID: 15181450)
21. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
22. Molecular targets from VHL studies into the oxygen-sensing pathway.
Maynard MA; Ohh M
Curr Cancer Drug Targets; 2005 Aug; 5(5):345-56. PubMed ID: 16101382
[TBL] [Abstract][Full Text] [Related]
23. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
24. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA; Ohh M
Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
[TBL] [Abstract][Full Text] [Related]
25. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953
[TBL] [Abstract][Full Text] [Related]
26. The von Hippel-Lindau tumor suppressor gene.
Kondo K; Kaelin WG
Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
[TBL] [Abstract][Full Text] [Related]
27. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
Pugh CW; Ratcliffe PJ
Semin Cancer Biol; 2003 Feb; 13(1):83-9. PubMed ID: 12507560
[TBL] [Abstract][Full Text] [Related]
28. VHL takes HIF's breath away.
Krek W
Nat Cell Biol; 2000 Jul; 2(7):E121-3. PubMed ID: 10878820
[TBL] [Abstract][Full Text] [Related]
29. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.
Blagosklonny MV
Oncogene; 2001 Jan; 20(3):395-8. PubMed ID: 11313969
[TBL] [Abstract][Full Text] [Related]
30. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells.
Alberghini A; Recalcati S; Tacchini L; Santambrogio P; Campanella A; Cairo G
J Biol Chem; 2005 Aug; 280(34):30120-8. PubMed ID: 15985433
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T
Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918
[TBL] [Abstract][Full Text] [Related]
32. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
[TBL] [Abstract][Full Text] [Related]
33. Regulation of ferrochelatase gene expression by hypoxia.
Liu YL; Ang SO; Weigent DA; Prchal JT; Bloomer JR
Life Sci; 2004 Sep; 75(17):2035-43. PubMed ID: 15312748
[TBL] [Abstract][Full Text] [Related]
34. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.
Barry RE; Krek W
Trends Mol Med; 2004 Sep; 10(9):466-72. PubMed ID: 15350900
[No Abstract] [Full Text] [Related]
35. [Cellular and tissue hypoxia--role of the von Hippel Lindau gene and hypoxia-inducible factor-1].
Sýkora V; Necas E
Cas Lek Cesk; 2003; 142(10):595-8. PubMed ID: 14635422
[TBL] [Abstract][Full Text] [Related]
36. Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma.
Chan CC; Lee YS; Zhuang Z; Hackett J; Chew EY
Trans Am Ophthalmol Soc; 2004; 102():75-9; discussion 79-81. PubMed ID: 15747747
[TBL] [Abstract][Full Text] [Related]
37. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.
Sang N; Fang J; Srinivas V; Leshchinsky I; Caro J
Mol Cell Biol; 2002 May; 22(9):2984-92. PubMed ID: 11940656
[TBL] [Abstract][Full Text] [Related]
38. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth.
Mack FA; Rathmell WK; Arsham AM; Gnarra J; Keith B; Simon MC
Cancer Cell; 2003 Jan; 3(1):75-88. PubMed ID: 12559177
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation.
Jung Y; Isaacs JS; Lee S; Trepel J; Liu ZG; Neckers L
Biochem J; 2003 Mar; 370(Pt 3):1011-7. PubMed ID: 12479793
[TBL] [Abstract][Full Text] [Related]
40. Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes.
Biju MP; Neumann AK; Bensinger SJ; Johnson RS; Turka LA; Haase VH
Mol Cell Biol; 2004 Oct; 24(20):9038-47. PubMed ID: 15456877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
